Early intervention in the prodrome of psychosis

Author/s
Clare Holt, Sophie Butler, Mark Agius
Citation
Issue 1 Summer 2011
CEPiP.2011.1.30-34
Abstract

One approach to intervening early in a psychotic illness is to initiate appropriate treatment in the prodromal phase of the illness with the aim to prevent or delay the first psychotic episode. Although still somewhat experimental, due to the growing evidence base, a number of clinics dedicated to this approach have been set up. We describe the identification of the prodrome, and explore the present evidence for its treatment.

Keywords: psychosis, prodrome, at risk mental states, medication, psychological interventions

Cite as: Cutting Edge Psychiatry in Practice 2011, 1(1):30-34; https://doi.org/10.65031/sxyb9245

References

  1. Jackson HJ, McGorry PD Dudgeon P Prodromal symptoms of schizophrenia in first episode psychosis; prevalence and specificity. Comprehensive Psychiatry 1995; 36:241-250. (published erratum in comprehensive psychiatry 37;75.). https://doi.org/10.1016/s0010-440x(95)90068-3
  2. Yung AR, McGorry PD The prodromal phase of first episode psychosis; past and current conceptualisations. Schizophrenia Bulletin 1996; 22: 353-370. https://doi.org/10.1093/schbul/22.2.353
  3. Yung AR, McGorry PD The initial prodrome in psychosis; descriptive and qualitative aspects Aust NZJ of Psychiatry 1996; 30;587-599. https://doi.org/10.3109/00048679609062654
  4. McGorry P et al. Early Psychosis training pack module 1; recognition Gardiner-Cauldwell. P1-29.1997.
  5. Hafner H et al Prodrome, onset and early course of Schizophrenia. In The Epidemiology of Schizophrenia ed. Murray R et al. Cambridge. Cambridge University Press p124-147.2003. https://doi.org/10.1017/cbo9780511544118.011
  6. Hafner H et al. IRAOS; an instrument for the retrospective assessment of the onset of schizophrenia. Schizophrenia Research 1992; 6, 209-223. 
  7. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Cannon T, Ventura J,et al Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes; preliminary evidence of interrater reliability and predictive validity.American Journal of Psychiatry 2002; 159:863-865 https://doi.org/10.1176/appi.ajp.159.5.863
  8. McGorry PD, Yung AR, Phillips LJ The ‘close in’ or ultra high risk model; A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophrenia Bulletin 2003; 29; 771-790. https://doi.org/10.1093/oxfordjournals.schbul.a007046
  9. Wolbrock T, Falkai P, Gaebel W Implementing early detection and intervention in psychosis; the german approach. In Ehmann T, Macewan GW,Honer W editors Best care in early psychosis intervention . London and New York Taylor and Francis p157-166.2004. https://doi.org/10.4324/9780203309421_chapter_3
  10. Agius M, Kelly C, Zaman R Metanalysis of medical and non medical treatments of the prodromal phase of psychotic illness, the so-called at risk mental states. European Neuropsychopharmacology 2008: 18 suppl 4 S441 https://doi.org/10.1016/s0924-977x(08)70649-7
  11. Kelly C, Hadjinicolaou AV, Holt C, Agius M & Zaman R:Meta-Analysis of Medical and non-medical treatments of the prodromal phase of psychotic illness in at-risk mental states. Psychiatr Danub. 2010 ;22 supp 1 ; 56-62 https://doi.org/10.1016/s0924-977x(08)70649-7
  12. McGorry PD, Yung AR, Phillips LJ, et al. Randomised controlled trial of interventions designed to reduce the risk of progression to firstepisode psychosis in a clinical sample with subthreshold symptoms Archives of General Psychiatry 2002; 59:921-928. https://doi.org/10.1001/archpsyc.59.10.921
  13. Woods SW, Tully EM, Walsh BC, Hawkins KA, Callahan JL, Cohen SJ, Mathalon DH, Miller TJ, McGlashan TH.,“Aripiprazole in the treatment of the psychosis prodrome. An open-label pilot study”, British Journal of Psychiatry, (2007) 191(suppl . 51), s96- s101. https://doi.org/10.1192/bjp.191.51.s96
  14. Morrison AP, Bentall RP, Walford FL, Kilcommons A, Knight A, Kreutz M, Lewis SW, “Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals Study design and interim analysis of transition rate and psychological risk factors”, British Journal of Psychiatry, (2002), 181 (suppl. 4 3), s 78- s 84 https://doi.org/10.1192/bjp.181.43.s78
  15. Morrison AP, French P, Walford L et al A randomised controlled trial of cognitive therapy for prevention of psychosis in people at ultra-high risk.Schizophrenia Research 2004; 67; 7. https://doi.org/10.1016/s0920-9964(03)80294-3
  16. Nordentoft M, Thorup A, Petersen L, Øhlenschlaeger J, Melau M, Christensen T, Krapup G, Jorgensen P, Jeppesen P,“Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment”, Schizophrenia Research, (2006) 83 ; 29– 40 https://doi.org/10.1016/j.schres.2006.01.002
  17. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller TJ, Woods SW,et al The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design. Schizophr Res. 2003; 61(1):7-18 https://doi.org/10.1016/s0920-9964(02)00439-5
  18. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. “Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis”, Am J Psychiatry, (2006) 163:790–799. https://doi.org/10.1176/appi.ajp.163.5.790
  19. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E, “The Schizophrenia Prodrome Revisited: ANeurodevelopmental Perspective”, Schizophrenia Bulletin, (2003) 29(4):633-651. https://doi.org/10.1093/oxfordjournals.schbul.a007036
  20. Cornblatt BA, Lencz T, Smith CW, Olsen R, Auther AM, Nakayama E, et al..Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007 ;68(4):546-57 https://doi.org/10.4088/jcp.v68n0410
  21. Bechdolf A, et al, “Randomized controlled multicentre trial of cognitive behaviour therapy in the early initial prodromal state:effects on social adjustment post treatment.” Early Intervention in Psychiatry 2007; 1: 71–78 https://doi.org/10.1111/j.1751-7893.2007.00013.x
  22. Berger G, Dell’Olio M, Amminger P, Cornblatt B ,Phillips L ,Yung A, et al Neuroprotection in emerging psychotic disorders. Early Intervention in Psychiatry 2007 ; 1: 114–127 https://doi.org/10.1111/j.1751-7893.2007.00021.x
  23. Ruhrmann S, Bechdolf A, Kühn KU, Wagner M, Schultze-Lutter F, Janssen B, Maurer K, Häfner H, Gaebel W, Möller HJ,Maier W, Klosterkötter J; LIPS study group, “Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis”, British Journal of Psychiatry , (2007) 191 (suppl . 51) , s88 - s95 . https://doi.org/10.1192/bjp.191.51.s88
  24. Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, Mackinnon A, McGorry PD, Berger GE. Long-Chain -3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial Arch Gen Psychiatry. 2010;67(2):146-154 https://doi.org/10.1001/archgenpsychiatry.2009.192
  25. Walker EF, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, et al. The relation of antipsychotic and antidepressant medication with baseline symptoms and symptom progression: a naturalistic study of the North American Prodrome Longitudinal Sample. Schizophr Res. 2009 ;115(1):50-7 https://doi.org/10.1016/j.schres.2009.07.023
  26. Pantelis C, Velakoulis D, McGorry PD,Wood SJ, et al Neuroanatomical abnormalities before and after onset of psychosis :a crossectional and longitudinal MRI comparison. Lancet (2003) 361:281-288. https://doi.org/10.1016/s0140-6736(03)12323-9
  27. Koutsouleris N, Schmitt GA, Gaser C et al Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. British ournal of Psychiatry (2009) 195:218-226. https://doi.org/10.1192/bjp.bp.108.052068